Pamicell Stock Price at 17,550 KRW... Down 6.15% from Previous Day
Pamisell has ranked among the top searched stocks for 16 days in the past month.
As of 10:30 AM on the 26th, Pamisell is trading at 17,550 KRW, down 6.15% from the previous day. This represents a 10.0% decline compared to October 6. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners are tentatively recorded as net buyers of 129,000 shares. Over the past five days, individual investors have net purchased 254,869 shares, while foreigners and institutions have net sold 165,232 shares and 90,913 shares, respectively.
On October 25, Pamisell was a market topic with the headline "Rise after FDA approval of Remdesivir in the US."
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "I Will Give Them a Chance for Self-Examination": Chinese Scientific Community Shaken by Influencer's Preemptive Whistleblowing
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
